Sebastian R. Indo
Santiago, RM 8380494, Chile
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Calreticulin-Mediated Quality Control of the Non-Classical MHC-I Molecule MICA: Implications for Immune Surveillance.
Journal: International journal of molecular sciences
Published: December 31, 2025
Alpha-Lipoic Acid-Mediated Inhibition of LTB4 Synthesis Suppresses Epithelial-Mesenchymal Transition, Modulating Functional and Tumorigenic Capacities in Non-Small Cell Lung Cancer A549 Cells.
Journal: Current therapeutic research, clinical and experimental
Published: July 19, 2024
Overexpression of REST Represses the Epithelial-Mesenchymal Transition Process and Decreases the Aggressiveness of Prostate Cancer Cells.
Journal: International journal of molecular sciences
Published: February 01, 2024
Epidemiological and clinical description of patients with oropharyngeal cancer treated in a public oncology referral hospital in Chile.
Journal: Ecancermedicalscience
Published: January 05, 2024
Giantin mediates Golgi localization of Gal3-O-sulfotransferases and affects salivary mucin sulfation in patients with Sjögren's disease.
Journal: JCI insight
Published: April 19, 2023
hsa-miR-424-5p and hsa-miR-513c-3p dysregulation mediated by IFN-γ is associated with salivary gland dysfunction in Sjögren's syndrome patients.
Journal: Journal of autoimmunity
Published: December 07, 2022
Cancer Stemness/Epithelial-Mesenchymal Transition Axis Influences Metastasis and Castration Resistance in Prostate Cancer: Potential Therapeutic Target.
Journal: International journal of molecular sciences
Published: October 27, 2022
Endothelin-1 induces changes in the expression levels of steroidogenic enzymes and increases androgen receptor and testosterone production in the PC3 prostate cancer cell line.
Journal: Oncology reports
Published: October 31, 2020
Knockdown of ZEB1 reverses cancer stem cell properties in prostate cancer cells.
Journal: Oncology reports
Published: August 10, 2020
New inhibitor targeting Acyl-CoA synthetase 4 reduces breast and prostate tumor growth, therapeutic resistance and steroidogenesis.
Journal: Cellular and molecular life sciences : CMLS
Published: February 11, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026